BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2657249)

  • 1. Thymomodulin: biological properties and clinical applications.
    Kouttab NM; Prada M; Cazzola P
    Med Oncol Tumor Pharmacother; 1989; 6(1):5-9. PubMed ID: 2657249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update and future perspectives of a thymic biological response modifier (Thymomodulin).
    Cazzola P; Mazzanti P; Kouttab NM
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):195-216. PubMed ID: 3325544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacodynamics of thymomodulin in elderly humans.
    Calsini P; Mocchegiani E; Fabris N
    Drugs Exp Clin Res; 1985; 11(9):671-4. PubMed ID: 3880053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymomodulin stimulates phagocytosis in vitro by rat macrophages and human polymorphonuclear cells.
    Braga PC; Piatti G; Dal Sasso M; Maci S; Blasi F
    J Chemother; 1993 Oct; 5(5):313-6. PubMed ID: 8106905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymomodulin enhances phagocytic and intracellular killing activities of polymorphonuclear leucocytes without increasing release of chemotactic factors.
    Lantero S; Oddera S; Silvestri M; Ottolini V; Sacco O; Rossi GA
    Monaldi Arch Chest Dis; 1993; 48(1):29-33. PubMed ID: 8472059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind clinical trial for the evaluation of the therapeutical effectiveness of a calf thymus derivative (Thymomodulin) in children with recurrent respiratory infections.
    Fiocchi A; Borella E; Riva E; Arensi D; Travaglini P; Cazzola P; Giovannini M
    Thymus; 1986; 8(6):331-9. PubMed ID: 3544353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calf thymus acid lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: second report.
    Valesini G; Barnaba V; Benvenuto R; Balsano F; Mazzanti P; Cazzola P
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1915-9. PubMed ID: 3501759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymomodulin increases the depressed production of superoxide anion by alveolar macrophages in patients with chronic bronchitis.
    Maiorano V; Chianese R; Fumarulo R; Costantino E; Contini M; Carnimeo R; Cazzola P
    Int J Tissue React; 1989; 11(1):21-5. PubMed ID: 2553636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scanning electron microscopy study of changes induced by thymomodulin on the morphology of mononuclear elements of peripheral blood from healthy subjects and patients with neoplasms].
    Cappellari A; Galvan D; Bagarella M; Busolo R; Corradi G; Cazzola P
    Boll Ist Sieroter Milan; 1986; 65(4):290-7. PubMed ID: 3790275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined administration of thymomodulin and interleukin 2 reverses T-cell unresponsiveness in mice infected with Mycobacterium bovis-BCG.
    Colizzi V; Cazzola P; Mazzanti P
    Int J Immunopharmacol; 1988; 10(3):271-5. PubMed ID: 3263332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effectiveness of thymomodulin in children with recurrent respiratory infections].
    Longo F; Lepore L; Agosti E; Panizon F
    Pediatr Med Chir; 1988; 10(6):603-7. PubMed ID: 3244540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circadian variability of IgE in children: effects of a thymic hormone (thymomodulin)].
    Pecora R; Cherubini V; Cardinale G; Bartolotta E
    Pediatr Med Chir; 1991; 13(3):277-8. PubMed ID: 1945995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with thymomodulin reduces airway hyperresponsiveness to methacholine.
    Bagnato A; Brovedani P; Comina P; Molinaro P; Scalzo C; Triolo VA; Milani G
    Ann Allergy; 1989 May; 62(5):425-8. PubMed ID: 2566293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perennial allergic rhinitis. Prophylaxis of acute episodes using thymomodulin].
    Marzari R; Mazzanti P; Cazzola P; Pirodda E
    Minerva Med; 1987 Nov; 78(22):1675-81. PubMed ID: 3696446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro reactivity of lymphocytes after the addition of immunostimulatory drugs].
    Vucković-Dekić L; Stanojević-Bakić N; Radosavljević D; Rajner L; Dekić M
    Srp Arh Celok Lek; 1995; 123(3-4):81-2. PubMed ID: 16296229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal effects of prostaglandin E2 (PGE2) and of thymic factor (TFX-thymomodulin) on bactericidal activity of human neutrophils.
    Szkaradkiewicz A; Kiczka W
    Mater Med Pol; 1989; 21(2):97-9. PubMed ID: 2488473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal effects of prostaglandin E2 (PGE2) and of thymic factor (TFX-thymomodulin) on bactericidal activity of human neutrophils.
    Szkaradkiewicz A; Kiczka W
    Mater Med Pol; 1989; 21(3):231-3. PubMed ID: 2491276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive effect of thymomodulin in recurrent respiratory infections in children].
    Galli L; de Martino M; Azzari C; Bernardini R; Cozza G; de Marco A; Lucarini D; Sabatini C; Vierucci A
    Pediatr Med Chir; 1990; 12(3):229-32. PubMed ID: 2274431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results.
    Galli M; Crocchiolo P; Negri C; Caredda F; Lazzarin A; Moroni M
    Drugs Exp Clin Res; 1985; 11(9):665-9. PubMed ID: 3916838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.
    Mirić M; Vasiljević J; Bojić M; Popović Z; Keserović N; Pesić M
    Heart; 1996 Jun; 75(6):596-601. PubMed ID: 8697164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.